Last reviewed · How we verify
Antacids
At a glance
| Generic name | Antacids |
|---|---|
| Sponsor | Digestive & Liver Disease Specialists |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults (PHASE1)
- rhTPO Dose Escalation vs Eltrombopag Switch in ITP (NA)
- Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile (NA)
- A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) (PHASE1)
- Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet (EARLY_PHASE1)
- Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection (PHASE2)
- Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia (PHASE2)
- Optimizing PTCy Dose and Timing (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |